Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Cigna has filed a lawsuit against Bristol Myers Squibb Company and its subsidiary Celgene Inc. for allegedly violating antitrust laws by maintaining a monopoly on the multiple myeloma drug Pomalyst. The company is currently facing civil allegations related to these antitrust claims.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
